// App-Quantinova.ai

1194 : Cross-cancer GWAS meta-analysis of more than 370,000 cases and 530,000 controls identifies multiple novel cancer risk regions

Researchers

Presenter

  • Sara Lindstrm

Principal Investigators

  • Lu Wang

  • Constance Turman

  • James MacDonald

  • Theo Bammler

  • BCAC, OCAC, PRACTICAL

  • Jeroen Huyghe

  • Stephanie Schmit

  • Tracy A. O'Mara

  • Deborah J. Thompson

  • Puya Gharahkhani

  • Stuart MacGregor

  • Paul Brennan

  • Richard S. Houlston

  • Beatrice S. Melin

  • Christopher I. Amos

  • James McKay

  • Mark M. Iles

  • Matthew H. Law

  • Alison Klein

  • Laufey Amundadottir

  • Bogdan Pasaniuc

  • Paul Pharoah

  • Rayjean J. Hung

  • Peter Kraft

Medical Centers

  • University of Washington, Seattle, WA

  • University of Bristol, Bristol, United Kingdom

  • Harvard School of Public Health, Boston, MA

  • Fred Hutchinson Cancer Resaerch Center, Seattle, WA

  • H. Lee Moffitt Cancer Center & Research Institute, Riverview, FL

  • QIMR Berghofer Medical Research Institute, Brisbane, Sydney, Australia

  • University of Cambridge, Cambridge, United Kingdom

  • International Agency for Research on Cancer, Lyon, France

  • The Institute of Cancer Research, Sutton, United Kingdom

  • Umea University, Umea, Sweden

  • Baylor College of Medicine, Houston, TX

  • University of Leeds, Leeds, United Kingdom

  • Johns Hopkins University School of Medicine, Baltimore, MD

  • National Cancer Institute, Bethesda, MD

  • University of Southern California, Los Angeles, CA

  • Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

  • University of Toronto, Toronto, ON, Canada

Locations

  • United States

  • United Kingdom

  • Australia

  • France

  • Sweden

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Type 2 diabetes mellitus

  • Renal cell carcinoma

  • Solid malignancies

  • Diabetes

  • Melanoma

  • Gliomas

Biomarkers

  • Ras Responsive Element Binding Protein 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved